ScaleReady Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

  • Investments
  • 9

ScaleReady General Information

Description

Developer of scalable manufacturing technologies intended to make the business of cell and gene therapy practical and viable. The company offers scalable technologies and processes needed to develop and commercialize new cell and gene therapies to researchers and biopharmaceutical companies, thereby enhancing the prospects of success for gene therapy organizations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2100 Old Highway 8 North West
  • New Brighton, MN 55112
  • United States
Primary Industry
Biotechnology
Corporate Office
  • 2100 Old Highway 8 North West
  • New Brighton, MN 55112
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ScaleReady Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ScaleReady‘s full profile, request access.

Request a free trial

ScaleReady Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ScaleReady Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ScaleReady‘s full profile, request access.

Request a free trial

ScaleReady Investments (9)

ScaleReady’s most recent deal was a Grant with Immumem Therapeutics for . The deal was made on 16-Jul-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immumem Therapeutics 16-Jul-2025 Grant Biotechnology
BrainChild Bio 21-Jan-2025 Grant Drug Discovery
Cartherics 18-Dec-2024 Accelerator/Incubator Drug Discovery
BioCytics 03-Dec-2024 Grant Drug Discovery
OverT Bio 22-Nov-2024 Grant Drug Discovery
You’re viewing 5 of 9 investments. Get the full list »

ScaleReady FAQs

  • When was ScaleReady founded?

    ScaleReady was founded in 2020.

  • Where is ScaleReady headquartered?

    ScaleReady is headquartered in New Brighton, MN.

  • What is the size of ScaleReady?

    ScaleReady has 25 total employees.

  • What industry is ScaleReady in?

    ScaleReady’s primary industry is Biotechnology.

  • Is ScaleReady a private or public company?

    ScaleReady is a Private company.

  • What is ScaleReady’s current revenue?

    The current revenue for ScaleReady is .

  • Who are ScaleReady’s investors?

    Bio-Techne, Fresenius Kabi, and Wilson Wolf Manufacturing have invested in ScaleReady.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process